Key facts
- It has raised $690K; the latest was Angel (individual) ($120K) in Sep 2025.
- Notable investors include BLOCK71, NUS Graduate Research Innovation Programme, National Additive Manufacturing Innovation Cluster.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for nusmetics
- ·The full record, as it builds
Funding rounds
No funding rounds for nusmetics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About nusmetics
Developer of micro-needle-based drug delivery technology designed for improved topical and transdermal administration. The company offers microscopic, mixable needle particles that are invisible to the eye, incorporated into existing formulations without complex processing, supporting skin penetration, reduced reliance on concentrations of active ingredients, customizable dosing, and compatibility with minimalist formulations, enabling clients to improve delivery performance, formulation efficiency, and product consistency while reducing material usage and application time.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2019
- Employees
- 3
- Website
- nusmetics.com/
- Ownership
- Privately Held (backing)
nusmetics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in nusmetics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on nusmetics in its N-PORT filings yet. We sweep new filings monthly.